Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 26.02
+0.20 (0.77%)
Oct 23, 2025, 2:45 PM CST
SHE:002262 Revenue
Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.50B CNY in the quarter ending June 30, 2025, with 6.64% growth. This brings the company's revenue in the last twelve months to 5.94B, up 9.99% year-over-year. In the year 2024, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.70B with 13.01% growth.
Revenue (ttm)
5.94B
Revenue Growth
+9.99%
P/S Ratio
4.41
Revenue / Employee
1.00M
Employees
5,923
Market Cap
26.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.70B | 656.13M | 13.01% |
| Dec 31, 2023 | 5.04B | 742.99M | 17.28% |
| Jan 1, 2023 | 4.30B | 362.85M | 9.22% |
| Jan 1, 2022 | 3.94B | 574.36M | 17.09% |
| Dec 31, 2020 | 3.36B | -788.01M | -18.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 42.62B |
| WuXi AppTec | 41.90B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |
| Shanghai Fosun Pharmaceutical (Group) | 40.12B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Jiangsu Hengrui Medicine | 30.15B |
| Zhejiang NHU Company | 22.87B |
| Aier Eye Hospital Group | 21.94B |